TrialJCO precision oncology2025

Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Stephen J Luen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.